Jorge Cortell

Jorge is the Senior Advisor, Health Care and Life Sciences, at Harvard University Innovation Laboratories. He's also on the Advisory Board at Lysando (world leader in antimicrobial proteins) and AugMend (VR for mental health), and former Venture Partner at NLC (Europe's most active early stage investor in healthcare with over 100 ventures, 7 of which co-built by Jorge). A serial entrepreneur, Jorge has founded 6 bootstrapped and profitable startups (5 exits and one shut down) in 3 countries and 5 industries, including a paper unicorn. His innovations in healthcare technology include introducing the first open-source model-independent AI application platform in healthcare (2019); designing and developing a multimodal platform for rapid diagnosis, intervention scenarios, and resource planning for pandemics (introduced days after Covid19 was declared a pandemic in 2019); inventing the first precision medicine software platform (2014); designing the first vendor-neutral digital pathology dicomizer (2012); and developing the first commercially available augmented reality system for surgery (in 2008). As educator, he has delivered keynote talks at events like HIMSS and RSNA, guest lectures at institutions like Oxford, Harvard, MIT, and Stanford, while having taught innovation at the Polytechnic University of Valencia and the Open University of Catalonia. He has also been an Innovation Fellow at Harvard University's School of Engineering and Applied Sciences Technology and Entrepreneurship Center. He's also a former professional basketball player, and member of the European Commission Expert Group on Venture Philanthropy and Social Investments. First generation college graduate at the University of Oxford (Computer Science), MIT (Entrepreneurship Development Program), and the University of Valencia (postgraduate in Clinical Genomics), he has received innovation and academic awards by: NASA, California Governor, HIMSS, IBM, Digital Pathology Association, Frost & Sullivan, and the Wall Street Journal.